BEUDAMED
    FDA Adverse Event Injury Summary report: N

    MOD UNITI CONV BASEPLATE S 24

    MDR report key: 23768417 · Received December 10, 2025

    Report

    Report Number
    1818910-2025-21568
    Event Type
    Injury
    Date Received
    December 10, 2025
    Date of Event
    November 19, 2025
    Manufacturer
    DEPUY IRELAND - 3015516266
    Product Code
    MBF
    UDI-DI
    10603295553212
    PMA / PMN Number
    K230831
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    OTHER
    Health Professional
    N

    Narratives

    Additional Manufacturer Narrative · 0

    PRODUCT COMPLAINT#: (B)(4). THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803 (AND/OR PART 4, AS APPLICABLE). THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY DEPUY SYNTHES, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, DEPUY SYNTHES, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. ADDITIONAL NARRATIVE: IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

    Additional Manufacturer Narrative · 0

    PRODUCT COMPLAINT # (B)(4). INVESTIGATION SUMMARY NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. THE PRODUCT INVESTIGATION FOUND NO EVIDENCE SUSPECTING AN ERROR IN THE MANUFACTURING OR MATERIAL THAT WOULD BE A CONTRIBUTING FACTOR IN THE REPORTED ALLEGATION(S). A RECORDS EVALUATION (MRE) WAS NOT PERFORM AS PART OF OUR COMPANY QUALITY SYSTEM PROCESS, ALL DEVICES ARE MANUFACTURED, INSPECTED, AND DISTRIBUTED TO APPROVED SPECIFICATIONS. ADDITIONAL COMPLAINT INFORMATION MONITORING FOR POTENTIAL SAFETY SIGNALS WILL BE CONDUCTED THROUGH COMPLAINT TRENDING AS PART OF THE POST-MARKET SURVEILLANCE. IF ADDITIONAL INFORMATION IS MADE AVAILABLE, THE INVESTIGATION WILL BE UPDATED AS APPLICABLE. DEVICE HISTORY LOT THE PRODUCT INVESTIGATION FOUND NO EVIDENCE SUSPECTING AN ERROR IN THE MANUFACTURING OR MATERIAL THAT WOULD BE A CONTRIBUTING FACTOR IN THE REPORTED ALLEGATION(S). A MANUFACTURING RECORDS EVALUATION (MRE) WAS NOT PERFORMED. H11 ADDITIONAL NARRATIVE: ADDED: D10.

    Description of Event or Problem · 0

    SUBJECT ID: (B)(6). STUDY NO: (B)(4). CLINICAL ADVERSE EVENT RECEIVED FOR WORSENING BILATERAL SHOULDER PAIN, DEVICE RELATED: NOT RELATED, PROCEDURE RELATED: POSSIBLE DATE OF EVENT: 19 NOV 2025, DATE OF IMPLANT: ON (B)(6) 2025, DATE OF REVISION: NO INFORMATION PROVIDED, DEVICE LOCATION: RIGHT. TREATMENT/IMPACT: REHABILITATION, INJECTED MEDICATION (TRIAMCINOLONE (KENALOG-40) INJECTION 20-120 MG). DEPUY SYNTHES PRODUCTS USED: CATALOG NUMBER: 520000040, LOT NUMBER: 662039, COMPONENT TYPE: HUMERAL, DESCRIPTION: INHANCE SHOULDER SYSTEM STEMLESS LARGE DIAMETER 40MM CEMENTLESS, CATALOG NUMBER: 550011240, LOT NUMBER: 663949, COMPONENT TYPE: BASEPLATE, DESCRIPTION: INHANCE SHOULDER SYSTEM MODULAR UNITI PLATFORM BASEPLATE SMALL Ø24MM CEMENTLESS, CATALOG NUMBER: 550300500, LOT NUMBER: 220085, COMPONENT TYPE: SCREW, DESCRIPTION: INHANCE SHOULDER SYSTEM SELF-DRILLING & LOCKING SCREW 4 PACK 20MM & 25MM, CATALOG NUMBER: 550035600, LOT NUMBER: 217704, COMPONENT TYPE: SCREW, DESCRIPTION: INHANCE SHOULDER SYSTEM CENTRAL SCREW Ø6.0 X 35MM, CATALOG NUMBER: 550532008, LOT NUMBER: 345531, COMPONENT TYPE: GLENOSPHERE, DESCRIPTION: INHANCE SHOULDER SYSTEM GLENOSPHERE Ø32+8MM, CATALOG NUMBER: 550000400, LOT NUMBER: 664523, COMPONENT TYPE: SHELL, DESCRIPTION: INHANCE SHOULDER SYSTEM REVERSE HUMERAL SHELL LARGE Ø40+0MM, CATALOG NUMBER: 550032100, LOT NUMBER: MI169614, COMPONENT TYPE: LINER, DESCRIPTION: INHANCE SHOULDER SYSTEM REVERSE LINER RETENTIVE X-LINKED VITAMIN E PE Ø32+0MM.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2884205 MOD UNITI CONV BASEPLATE S 24 SHOULDER IMPLANT - METAGLENE MBF DEPUY IRELAND - 3015516266 663949 10603295553212

    Patients

    Seq Age Sex Outcome Treatment
    1 68 YR Female Required Intervention